Email address
[email protected]Contact number
+1 617 951 7000Provided by Ropes & Gray LLP
The attorneys and technical specialists who make up the global life sciences group understand the unique needs of a wide range of clients in the dynamic life sciences industry. We work across practices and geographies to develop cutting-edge solutions that help our clients meet their business goals.
To learn more about our practice, please visit: https://www.ropesgray.com/practices/life-sciences.aspx
Provided by Chambers
Ropes & Gray LLP is reputed for high end M&A, capital markets transactions and complex licensing and collaboration deals. The team is well equipped to assist with matters at the intersection of FDA product labeling rules and the First Amendment, contentious regulatory proceedings and patent disputes.
Provided by Ropes & Gray LLP
Ropes & Gray represented Pfizer in an $11.6 billion agreement to acquire Biohaven Pharmaceuticals, the maker of Nurtec ODT, an innovative dual-acting migraine therapy.
Provided by Chambers
"I can't sing Ropes & Gray's praises highly enough - the firm is absolutely excellent. The team is attentive and can meet tough timelines while being very detail-oriented."
"The Ropes & Gray team brings considerable experience to the table."
"I can't sing Ropes & Gray's praises highly enough - the firm is absolutely excellent. The team is attentive and can meet tough timelines while being very detail-oriented."
"The Ropes & Gray team brings considerable experience to the table."
Provided by Chambers
Marc Rubenstein is considered one of the nation's leading experts on complex strategic licensing and collaborative research arrangements. He cochairs the firm's life sciences and healthcare practice.
Paul Kinsella has extensive experience representing life sciences companies in capital markets transactions and M&A.
David McIntosh advises investors, businesses and research institutions on IP-driven transactions such as M&A, joint ventures, collaborations and licensing arrangements of all kinds.